Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea · Delayed Price · Currency is KRW
13,900
-250 (-1.77%)
Apr 10, 2026, 3:30 PM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | | 9.48B | 8.05B | 9.69B | 12.36B | 24.32B | | | |
| | | 17.73% | -16.89% | -21.61% | -49.16% | 15.48% | | | |
| | | - | -202.09M | -451.48M | - | -36.43M | | | |
| | | - | - | 2.22M | 148.85M | 5.81B | | | |
| | | - | - | -98.51% | -97.44% | -58.54% | | | |
| | | 9.48B | 7.85B | 9.24B | 12.51B | 30.09B | | | |
| | | 20.76% | -15.04% | -26.14% | -58.41% | -3.68% | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | | 284.50M | 3.96B | 8.13B | 12.16B | 2.62B | | | |
| | | -92.82% | -51.23% | -33.15% | 364.57% | -87.54% | | | |
| | | 9.20B | 3.89B | 1.11B | 353.24M | 27.47B | | | |
| | | 136.59% | 249.16% | 215.18% | -98.71% | 168.57% | | | |
| | | 9.48B | 7.85B | 9.24B | 12.51B | 30.09B | | | |
| | | 20.76% | -15.04% | -26.14% | -58.41% | -3.68% | | | |
Source: S&P Global Market Intelligence.